Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
The American Journal of Medicine|October 1, 2008
Surgical and obstetric outcomes in adults with sickle cell diseaseSoheir Adam, Jude Jonassaint, Hillary Kruger, et al.
British Journal of Haematology|February 18, 2011
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043)Kenneth I Ataga, Marvin Reid, Samir K Ballas, et al.
British Journal of Haematology|October 30, 2015
Coagulation activation in sickle cell trait: an exploratory studyChirag Amin, Soheir Adam, Micah J Mooberry, et al.
Blood Advances|January 11, 2024
Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panelDeva Sharma, Ilknur Kozanoğlu, Kenneth I Ataga, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
Plos One|September 27, 2016
Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell AnemiaKenneth I Ataga, Vimal K Derebail, Melissa Caughey, et al.
American Journal of Hematology|October 9, 2018
Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysisAbdullah Kutlar, Julie Kanter, Darla K Liles, et al.
Haematologica|November 12, 2020
Rapid decline in estimated glomerular filtration rate in sickle cell anemia: results of a multicenter pooled analysisKenneth I Ataga, Qingning Zhou, Vimal K Derebail, et al.
Pediatric Blood & Cancer|February 8, 2018
Nephrin as a biomarker of sickle cell glomerulopathy in MalawiJ Brett Heimlich, Godwin Chipoka, Laila Elsherif, et al.
British Journal of Haematology|February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesRobyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
Pageof 12